Mariana Raffo Pereda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mariana Raffo Pereda has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Ana Laura e Silva Aidar
Universidade Federal de São Paulo (Unifesp), Brazil
3 shared publications - Brena Costa dos Santos
Universidade Federal de São Paulo (Unifesp), Brazil
3 shared publications - Danielle Akemi Bergara Kuramoto
Universidade Federal de São Paulo, Brazil
3 shared publications - Jorge Eduardo de Amorim
Universidade Federal de Sao Paulo, Brasil
3 shared publications - Luis Carlos Uta Nakano
Division of Vascular and Endovascular Surgery, Universidade Federal de Sao Paulo, Sao Paulo, Brazil
3 shared publications - Rebeca Mangabeira Correia
Universidade Federal de São Paulo, Brazil
3 shared publications
Latest Publications
- Open Access
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Sao Paulo Medical Journal
- Vol. 141 (5)
Vascular complications in 305 severely ill patients with COVID-19: a cohort study
Although an association has been made between coronavirus disease 2019 (COVID-19) and microvascular disease, data on vascular complications (other than venous thromboembolism) are sparse. To investigate the vascular complications in severely ill patients hospitalized with COVID-19 and their association with all-cause mortality. This cohort study was conducted at the Universidade Federal de São Paulo, Brazil. All 305 consecutive patients diagnosed with COVID-19 and hospitalized in the intensive care unit (ICU) of a tertiary university hospital from April 2 to July 17, 2021, were included and followed up for 30 days. Of these, 193 (63.3%) were male, and the mean age was 59.9 years (standard deviation = 14.34). The mortality rate was 56.3% (172 patients), and 72 (23.6%) patients developed at least one vascular complication during the follow-up period. Vascular complications were more prevalent in the non-survivors (28.5%) than in the survivors (17.3%) group and included disseminated intravascular coagulation (DIC, 10.8%), deep vein thrombosis (8.2%), acrocyanosis (7.5%), and necrosis of the extremities (2%). DIC (adjusted odds ratio (aOR) 2.30, 95% confidence interval (CI) 1.01–5.24, P = 0.046) and acrocyanosis (aOR 5.21, 95% CI 1.48–18.27, P = 0.009) were significantly more prevalent in the non-survivors than in the survivors group. Vascular complications in critically ill COVID-19 patients are common (23.6%) and can be closely related to the mortality rate (56.3%) until 30 days after ICU admission. Macrovascular complications have direct implications for mortality, which is the main outcome of the management of COVID-19. RBR-4qjzh7 (https://ensaiosclinicos.gov.br/rg/RBR-4qjzh7).
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Sao Paulo Medical Journal
- Vol. 141 (5)
Open AccessVascular complications in 305 severely ill patients with COVID-19: a cohort study
Although an association has been made between coronavirus disease 2019 (COVID-19) and microvascular disease, data on vascular complications (other than venous thromboembolism) are sparse. To investigate the vascular complications in severely ill patients hospitalized with COVID-19 and their association with all-cause mortality. This cohort study was conducted at the Universidade Federal de São Paulo, Brazil. All 305 consecutive patients diagnosed with COVID-19 and hospitalized in the intensive care unit (ICU) of a tertiary university hospital from April 2 to July 17, 2021, were included and followed up for 30 days. Of these, 193 (63.3%) were male, and the mean age was 59.9 years (standard deviation = 14.34). The mortality rate was 56.3% (172 patients), and 72 (23.6%) patients developed at least one vascular complication during the follow-up period. Vascular complications were more prevalent in the non-survivors (28.5%) than in the survivors (17.3%) group and included disseminated intravascular coagulation (DIC, 10.8%), deep vein thrombosis (8.2%), acrocyanosis (7.5%), and necrosis of the extremities (2%). DIC (adjusted odds ratio (aOR) 2.30, 95% confidence interval (CI) 1.01–5.24, P = 0.046) and acrocyanosis (aOR 5.21, 95% CI 1.48–18.27, P = 0.009) were significantly more prevalent in the non-survivors than in the survivors group. Vascular complications in critically ill COVID-19 patients are common (23.6%) and can be closely related to the mortality rate (56.3%) until 30 days after ICU admission. Macrovascular complications have direct implications for mortality, which is the main outcome of the management of COVID-19. RBR-4qjzh7 (https://ensaiosclinicos.gov.br/rg/RBR-4qjzh7).
- Open Access
- 14 March 2022
- Published by FapUNIFESP (SciELO) in Sao Paulo Medical Journal
- Vol. 140 (2) , 320-327
What do Cochrane systematic reviews say about congenital vascular anomalies and hemangiomas? A narrative review
BACKGROUND: Congenital vascular anomalies and hemangiomas (CVAH) such as infantile hemangiomas, port-wine stains and brain arteriovenous malformations (AVMs) impair patients' lives and may require treatment if complications occur. However, a great variety of treatments for those conditions exist and the best interventions remain under discussion. OBJECTIVE: To summarize Cochrane systematic review (SR) evidence on treatments for CVAH. DESIGN AND SETTING: Review of SRs conducted in the Division of Vascular and Endovascular Surgery of Universidade Federal de Sao Paulo, Brazil. METHODS: A broad search was conducted on March 9, 2021, in the Cochrane Database of Systematic Reviews to retrieve any Cochrane SRs that assessed treatments for CVAH. The key characteristics and results of all SRs included were summarized and discussed. RESULTS: A total of three SRs fulfilled the inclusion criteria and were presented as a qualitative synthesis. One SR reported a significant clinical reduction of skin redness by at least 20%, with more pain, among 103 participants with port-wine stains. One SR reported that propranolol improved the likelihood of clearance 13 to 16-fold among 312 children with hemangiomas. One SR reported that the relative risk of death or dependence was 2.53 times greater in the intervention arm than with conservative management, among 218 participants with brain AVMs. CONCLUSION: Cochrane reviews suggest that treatment of port-wine stains with pulsed-dye laser improves redness; propranolol remains the best option for infantile hemangiomas; and conservative management seems to be superior to surgical intervention for treating brain AVMs.
- 14 March 2022
- Published by FapUNIFESP (SciELO) in Sao Paulo Medical Journal
- Vol. 140 (2) , 320-327
Open AccessWhat do Cochrane systematic reviews say about congenital vascular anomalies and hemangiomas? A narrative review
BACKGROUND: Congenital vascular anomalies and hemangiomas (CVAH) such as infantile hemangiomas, port-wine stains and brain arteriovenous malformations (AVMs) impair patients' lives and may require treatment if complications occur. However, a great variety of treatments for those conditions exist and the best interventions remain under discussion. OBJECTIVE: To summarize Cochrane systematic review (SR) evidence on treatments for CVAH. DESIGN AND SETTING: Review of SRs conducted in the Division of Vascular and Endovascular Surgery of Universidade Federal de Sao Paulo, Brazil. METHODS: A broad search was conducted on March 9, 2021, in the Cochrane Database of Systematic Reviews to retrieve any Cochrane SRs that assessed treatments for CVAH. The key characteristics and results of all SRs included were summarized and discussed. RESULTS: A total of three SRs fulfilled the inclusion criteria and were presented as a qualitative synthesis. One SR reported a significant clinical reduction of skin redness by at least 20%, with more pain, among 103 participants with port-wine stains. One SR reported that propranolol improved the likelihood of clearance 13 to 16-fold among 312 children with hemangiomas. One SR reported that the relative risk of death or dependence was 2.53 times greater in the intervention arm than with conservative management, among 218 participants with brain AVMs. CONCLUSION: Cochrane reviews suggest that treatment of port-wine stains with pulsed-dye laser improves redness; propranolol remains the best option for infantile hemangiomas; and conservative management seems to be superior to surgical intervention for treating brain AVMs.
- Open Access
- 1 January 2021
- Published by FapUNIFESP (SciELO) in Jornal Vascular Brasileiro
- Vol. 20
Recomendações de uso de equipamentos de proteção individual (EPIs) em procedimentos cirúrgicos durante a pandemia de SARS-Cov
Resumo Desde a classificação da doença por coronavírus 2019 (COVID-19) como pandemia pela Organização Mundial de Saúde (OMS), muitas medidas foram propostas com o intuito de diminuir os riscos e a chance de contaminação pelo novo coronavírus. Nesse contexto, o uso de equipamentos de proteção individual (EPIs) é de suma importância, especialmente em ambientes hospitalares e em situações que envolvem o cuidado em saúde, visto que o grau de exposição é notadamente maior no subgrupo de profissionais de saúde. Este artigo tem como objetivo propor um roteiro de uso de EPIs para procedimentos cirúrgicos. As recomendações sugeridas são estruturadas com base nas diretrizes do Ministério da Saúde e da OMS, e cinco roteiros de uso de EPIs foram sugeridos para os procedimentos mais comumente realizados: passagem de acesso venoso central; passagem de cateteres que necessitem de escopia; cirurgias abertas; angiografia diagnóstica e terapêutica; e curativos.
- 1 January 2021
- Published by FapUNIFESP (SciELO) in Jornal Vascular Brasileiro
- Vol. 20
Open AccessRecomendações de uso de equipamentos de proteção individual (EPIs) em procedimentos cirúrgicos durante a pandemia de SARS-Cov
Resumo Desde a classificação da doença por coronavírus 2019 (COVID-19) como pandemia pela Organização Mundial de Saúde (OMS), muitas medidas foram propostas com o intuito de diminuir os riscos e a chance de contaminação pelo novo coronavírus. Nesse contexto, o uso de equipamentos de proteção individual (EPIs) é de suma importância, especialmente em ambientes hospitalares e em situações que envolvem o cuidado em saúde, visto que o grau de exposição é notadamente maior no subgrupo de profissionais de saúde. Este artigo tem como objetivo propor um roteiro de uso de EPIs para procedimentos cirúrgicos. As recomendações sugeridas são estruturadas com base nas diretrizes do Ministério da Saúde e da OMS, e cinco roteiros de uso de EPIs foram sugeridos para os procedimentos mais comumente realizados: passagem de acesso venoso central; passagem de cateteres que necessitem de escopia; cirurgias abertas; angiografia diagnóstica e terapêutica; e curativos.